Key Takeaways
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion.
2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
Analyst consensus price target sits near $509, reflecting a generally constructive outlook despite mixed rating changes.
Shares dipped after earnings on cautious guidance but have since stabilized.
Restructuring initiatives and clean energy investments position Linde for potential margin expansion in 2026.
Street forecasts call for roughly 4.4% revenue growth to $35.5 billion next year.
Market Snapshot: Premium Valuation, Steady Fundamentals
Linde plc shares have navigated a volatile industrial backdrop with relative resilience. After an initial post-earnings pullback, the stock has recovered and stabilized, reflecting investor confidence in its strong cash flow profile and high-visibility project pipeline.
Operating margins remain best-in-class within the industrial gases sector, supported by disciplined pricing and ongoing productivity initiatives. While traditional manufacturing volumes face pressure, growth in electronics, clean energy, and specialty gases continues to anchor the long-term thesis.
Earnings Review: Beat on Results, Caution on Outlook
Linde’s Q4 2025 results modestly exceeded expectations:
Adjusted EPS: $4.20 (vs. $4.18 consensus)
Revenue: $8.76 billion (up 6.3% year-over-year)
Operating cash flow: $3.0 billion (up 8%)
Full-year revenue reached $34 billion, with underlying sales growth of 3%, driven by 2% pricing gains and 1% volume growth from project startups.
The company returned $7.4 billion to shareholders in 2025 through dividends and buybacks, underscoring its commitment to capital returns.
Why Shares Initially Declined
Despite the earnings beat, shares fell more than 2% following the release. The reaction stemmed from 2026 guidance viewed as conservative:
Full-year 2026 EPS guidance: $17.40–$17.90
Q1 2026 EPS guidance: $4.20–$4.30
The midpoint of full-year guidance came in slightly below consensus expectations of $17.83. Management assumed flat base volumes and a modest 1% foreign exchange tailwind, reflecting ongoing softness in manufacturing and chemicals.
Project Backlog: Growth Visibility Into 2026
A central pillar of Linde’s investment case is its record $10 billion project backlog — approximately two-thirds tied to clean energy initiatives.
Management expects $2.5–$3.0 billion in projects to begin operations during 2026, providing incremental revenue visibility. Key areas include:
Hydrogen infrastructure
Carbon capture and storage
Electronics and semiconductor-related gases
Demand linked to AI-driven semiconductor production continues to offset cyclical industrial weakness in other segments.
Analyst Reaction: Mixed but Generally Constructive
Analyst responses following earnings were varied:
Downgrades:
JPMorgan lowered its rating to Neutral from Overweight, citing flat organic growth and potential pricing pressures.
DZ Bank downgraded to Hold from Buy.
Target Increases and Positive Views:
Morgan Stanley raised its target to $530 (Buy).
UBS lifted its target to $550.
Citi increased its target to $545.
Mizuho raised its target to $525.
BMO Capital moved its target to $507 (Outperform).
Consensus price targets cluster around $509–$510, suggesting moderate upside from recent trading levels near $468.
Restructuring and Margin Expansion
Linde recorded $230 million in restructuring charges during Q4 as part of cost optimization efforts. Benefits are expected to materialize in the second half of 2026.
Management continues to target annual margin expansion of 30–50 basis points, driven by:
Productivity improvements
Portfolio optimization
Pricing discipline
Network density efficiencies
Helium and rare gas oversupply created a 1–2% EPS headwind during the quarter, but long-term fundamentals in specialty gases remain intact.
Capital expenditures are guided to $5.0–$5.5 billion in 2026, supporting backlog execution and growth projects.
2026 Outlook: Key Factors to Watch
1. Clean Energy and Electronics Momentum
Execution on backlog projects — particularly hydrogen and electronics-related facilities — will be critical. Semiconductor capacity expansion and AI infrastructure growth remain structural demand drivers for specialty gases.
2. Industrial Volume Recovery
European manufacturing weakness and global industrial softness remain near-term headwinds. A cyclical recovery could provide incremental upside beyond current guidance assumptions.
3. Margin Discipline
Investors will monitor whether restructuring benefits exceed the historical 30–50 basis point annual expansion range. Return on capital remains strong in the low-to-mid 20% range despite elevated CapEx.
4. Commodity and Specialty Gas Pricing
Helium oversupply and rare gas pricing pressures bear watching, particularly if industrial demand remains subdued.
Bottom Line
Linde continues to demonstrate operational discipline, strong cash generation, and long-term growth visibility through its record backlog. While conservative 2026 guidance prompted an initial selloff, underlying fundamentals — including pricing power, clean energy investments, and semiconductor-driven demand — remain intact.
Tickeron AI Perspective
Disclaimers and Limitations
LIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 37 cases where LIN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 57%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIN advanced for three days, in 155 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LIN as a result. In 34 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 39%.
The Moving Average Convergence Divergence Histogram (MACD) for LIN turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 20 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
The Aroon Indicator for LIN entered a downward trend on September 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. LIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.501) is normal, around the industry mean (6.559). P/E Ratio (30.079) is within average values for comparable stocks, (36.582). Projected Growth (PEG Ratio) (1.807) is also within normal values, averaging (2.076). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (6.150) is also within normal values, averaging (62.737).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of industrial gas
Industry ChemicalsSpecialty